Didronel and Omeprazole drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Didronel (etidronate disodium) and Omeprazole (omeprazole). Common drug interactions include burning sensation among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Didronel and Omeprazole. It is created by eHealthMe based on reports of 82 people who take the same drugs from the FDA, and is updated regularly.
What is Didronel?
Didronel has active ingredients of etidronate disodium. eHealthMe is studying from 1,587 Didronel users. Check the latest studies of Didronel.
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
82 people who take Didronel and Omeprazole together, and have interactions are studied.

What are the common drug interactions of Didronel and Omeprazole, by gender? *:
female:
- Burning sensation
- Cardiomegaly (increased size of heart than normal)
- Cellulitis (infection under the skin)
- Colonic perforation (a hole in the colon)
- Comminuted fracture (bone has broken into several pieces)
- Confusion
- Coronary artery atherosclerosis (life-threatening blockages in the arteries of your heart)
- Cough
- Cystitis haemorrhagic (blood in the urine and painful voiding)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
male:
- Drug ineffective
- Red cell aplasia (a type of anaemia affecting the precursors to red blood cells)
- Confusion
- Confusional state
- Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
- Deja vu (the experience of thinking that a new situation had occurred before)
- Disseminated carcinoma (spread of cancer)
- Grand mal convulsion (a type of generalized seizure that affects the entire brain)
- Hallucination (an experience involving the perception of something not present)
- Loss of consciousness
What are the common drug interactions of Didronel and Omeprazole, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue)
- Chest pain
- Disseminated carcinoma (spread of cancer)
50-59:
- Abnormal behaviour
- Confusional state
- Dyspnoea (difficult or laboured respiration)
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
- Hallucination (an experience involving the perception of something not present)
- Multi-organ failure (multisystem organ failure)
- Nausea (feeling of having an urge to vomit)
- Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
- Pulmonary granuloma (tiny lump of inflamed tissue in the lungs)
- Splenic artery aneurysm (enlargement of splenic artery)
60+:
- Abdominal pain
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Lower respiratory tract infection
- Pleural effusion (water on the lungs)
- Red cell aplasia (a type of anaemia affecting the precursors to red blood cells)
- Respiratory distress (difficulty in breathing)
- Splenic infarction (tissue damage of spleen)
- Acute pulmonary oedema (sudden deposit of fluid in the lung))
- Alanine aminotransferase increased
- Blood glucose increased
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 34 people, 41.46%
- Osteoporosis (bones weak and more likely to break): 11 people, 13.41%
- Polymyalgia Rheumatica (pain in many muscles): 5 people, 6.10%
* Approximation only. Some reports may have incomplete information.
Do you take Didronel and Omeprazole?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Didronel (1,587 reports)
- Omeprazole (410,631 reports)
Browse all drug interactions of Didronel and Omeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Didronel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Omeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Didronel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Omeprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on etidronate disodium and omeprazole (the active ingredients of Didronel and Omeprazole, respectively), and Didronel and Omeprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Nicotine cause Throat Irritation? - a second ago
- Could Zometa cause Intestinal Ischaemia? - 2 seconds ago
- Could Zolpidem cause Tinnitus? - 4 seconds ago
- Could Exjade cause Protein Urine Present? - 4 seconds ago
- Impaired Gastric Emptying and Hiatal Hernia - 7 seconds ago
- Could Niaspan cause Neck Pain? - 7 seconds ago
- Could Zolpidem cause Sleep Paralysis? - 7 seconds ago
- Drug interactions of Dolobid and Vitamin D - 8 seconds ago
- Could Nicorette cause Throat Tightness? - 13 seconds ago
- Could Niaspan cause Rhabdomyolysis? - 15 seconds ago